Get the Stockscreener App
12.01
1.50%
-0.010
Oric Pharmaceuticals Inc stock is traded at $12.01, with a volume of 34,274.
It is down -1.50% in the last 24 hours and up +15.54% over the past month.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
See More
Previous Close:
$12.00
Open:
$11.74
24h Volume:
34,274
Relative Volume:
0.03
Market Cap:
$1.17B
Revenue:
-
Net Income/Loss:
$-137.25M
P/E Ratio:
-6.3545
EPS:
-1.89
Net Cash Flow:
$-121.97M
1W Performance:
+13.00%
1M Performance:
+15.54%
6M Performance:
+113.74%
1Y Performance:
+17.73%
1-Day Range:
$11.64
$12.03
1-Week Range:
$10.19
$12.05
52-Week Range:
$3.8951
$14.67
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
Name
Oric Pharmaceuticals Inc
Sector
Industry
Phone
(650) 388-5600
Address
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
Compare ORIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORIC
Oric Pharmaceuticals Inc
|
12.03 | 1.17B | 0 | -137.25M | -121.97M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.28 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
583.12 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.31 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
772.47 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.31 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Resumed | Guggenheim | Buy |
| Jul-08-25 | Initiated | Ladenburg Thalmann | Buy |
| Oct-31-24 | Initiated | Wells Fargo | Overweight |
| Sep-06-24 | Initiated | Stifel | Buy |
| Feb-23-24 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-22-23 | Initiated | Wedbush | Outperform |
| Mar-23-23 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Mar-21-23 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-16-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-18-22 | Resumed | Oppenheimer | Perform |
| Apr-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Mar-25-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-22-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-22-22 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-06-21 | Upgrade | Citigroup | Neutral → Buy |
| Jan-25-21 | Downgrade | Citigroup | Buy → Neutral |
| Aug-13-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Upgrade | Citigroup | Neutral → Buy |
| Aug-03-20 | Initiated | H.C. Wainwright | Buy |
| May-19-20 | Initiated | Citigroup | Neutral |
| May-19-20 | Initiated | Guggenheim | Buy |
| May-19-20 | Initiated | JP Morgan | Overweight |
| May-19-20 | Initiated | Jefferies | Buy |
View All
Oric Pharmaceuticals Inc Stock (ORIC) Latest News
Is ORIC Pharmaceuticals Inc. stock poised for growth2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
Identifying reversal signals in ORIC Pharmaceuticals Inc.Trade Analysis Summary & Comprehensive Market Scan Insights - newser.com
Will ORIC Pharmaceuticals Inc. stock attract ESG investorsMarket Weekly Review & Daily Growth Stock Investment Tips - newser.com
How higher bond yields impact ORIC Pharmaceuticals Inc. (4TZ) stock2025 EndofYear Setup & AI Enhanced Execution Alerts - newser.com
ORIC Pharmaceuticals Inc 4TZ Stock Analysis and ForecastMarket Correction Analysis & Expert-Backed Recommendations That Deliver - earlytimes.in
Published on: 2025-09-29 09:52:14 - newser.com
Candlestick signals on ORIC Pharmaceuticals Inc. stock todayRisk Management & Consistent Profit Alerts - newser.com
Top chart patterns to watch in ORIC Pharmaceuticals Inc.Trade Performance Summary & Growth Focused Entry Point Reports - newser.com
ORIC Pharmaceuticals Inc Stock Analysis and ForecastLow Risk Investment Ideas & Learn the Secrets of Pro Traders - Early Times
Merus NV and ORIC Pharmaceuticals Inc at Citi BioPharma Conferen - GuruFocus
How robust is ORIC Pharmaceuticals Inc. (4TZ) stock financial positionMarket Sentiment Summary & Breakout Confirmation Trade Signals - newser.com
Cantor Fitzgerald reiterates Overweight rating on ORIC Pharmaceuticals stock By Investing.com - Investing.com Canada
Palumbo Wealth Management LLC Takes Position in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) CEO Sells $1,350,000.00 in Stock - MarketBeat
Rhumbline Advisers Decreases Stock Position in Oric Pharmaceuticals, Inc. $ORIC - Defense World
Should you hold or exit ORIC Pharmaceuticals Inc. now2025 Year in Review & Daily Profit Maximizing Tips - newser.com
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives $17.29 Average PT from Analysts - MarketBeat
Real time scanner hits for ORIC Pharmaceuticals Inc. explainedTrade Risk Assessment & Expert Approved Momentum Trade Ideas - newser.com
How to use a screener to detect ORIC Pharmaceuticals Inc. breakoutsTake Profit & Verified Momentum Stock Ideas - newser.com
Stock Recap: What are ORIC Pharmaceuticals Incs recent SEC filings showingWeekly Investment Report & Advanced Swing Trade Entry Alerts - خودرو بانک
Is ORIC Pharmaceuticals Inc. trending in predictive chart modelsJuly 2025 News Drivers & Weekly Breakout Opportunity Watchlist - newser.com
US Stocks Recap: Does ORIC Pharmaceuticals Inc. align with a passive investing strategyJuly 2025 Breakouts & Verified Momentum Watchlists - خودرو بانک
Will ORIC Pharmaceuticals Inc. outperform the marketShort Setup & Weekly Market Pulse Updates - newser.com
Risk Check: What’s ORIC Pharmaceuticals Inc.’s historical return2025 Sector Review & Smart Money Movement Tracker - خودرو بانک
How institutional ownership impacts ORIC Pharmaceuticals Inc. stockJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com
How to recover losses in ORIC Pharmaceuticals Inc. stockEarnings Risk Report & Safe Entry Zone Identification - newser.com
Quarterly Risk: Will ORIC Pharmaceuticals Inc benefit from current market trendsLayoff News & Safe Entry Point Identification - خودرو بانک
Oric Pharmaceuticals Inc Stock (ORIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):